Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Wall Street Loves FIGS—Why Do Price Targets Predict Pullback?:
Wall Street Loves FIGS—Why Do Price Targets Predict Pullback?

After a stunning plunge following its 2021 IPO, medical and lifestyle apparel company FIGS, Inc. (NYSE: FIGS) has roared back to life, trading at a price it hasn’t touched in nearly four years

FCX's Unit Cash Costs Surge in Q4: Is It Set to Climb Further in Q1?
FCX's Unit Cash Costs Surge in Q4: Is It Set to Climb Further in Q1?

Freeport-McMoRan Inc. FCX saw a sharp increase in its average unit net cash cost per pound of copper in the fourth quarter of 2025 to $2.22 from $1.40 in the prior quarter, marking a roughly 59%

FAF Stock Near 52-Week High: A Signal for Investors to Hold Tight?
FAF Stock Near 52-Week High: A Signal for Investors to Hold Tight?

Shares of First American Financial Corporation FAF closed at $69.57 on Wednesday, near its 52-week high of $71.47. This proximity underscores investor confidence. It has the ingredients for further

USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in USANA Health Sciences (USNA) lately. While the stock has lost 9.1% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its

Is Standard Motor Products (SMP) Stock Outpacing Its Auto-Tires-Trucks Peers This Year?
Is Standard Motor Products (SMP) Stock Outpacing Its Auto-Tires-Trucks Peers This Year?

For those looking to find strong Auto-Tires-Trucks stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Standard Motor Products (SMP) been one of those

Is MasterCraft Boat (MCFT) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is MasterCraft Boat (MCFT) Stock Outpacing Its Consumer Discretionary Peers This Year?

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has MasterCraft Boat Holdings, Inc. (MCFT) been

Monster Beverage's Stock Falls 9% Post Q4 Earnings: What to Know?
Monster Beverage's Stock Falls 9% Post Q4 Earnings: What to Know?

Shares of Monster Beverage Corporation MNST have lost 9.3% since it reported its fourth-quarter 2025 earnings on Feb. 26, 2025. Despite reporting a solid fourth-quarter performance, investors’

AXP's Big Game Plan: Turning Stadium Cheers Into Card Swipes
AXP's Big Game Plan: Turning Stadium Cheers Into Card Swipes

American Express Company AXP is doubling down on sports and entertainment through new partnerships that deepen its presence across major U.S. stadiums and professional teams. It will become the

Box (BOX) Upgraded to Buy: What Does It Mean for the Stock?
Box (BOX) Upgraded to Buy: What Does It Mean for the Stock?

Box (BOX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of

Waters (WAT) Upgraded to Buy: What Does It Mean for the Stock?
Waters (WAT) Upgraded to Buy: What Does It Mean for the Stock?

Waters (WAT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices

Ross Stores Proves the Off-Price Uptrend Is Far From Over
Ross Stores Proves the Off-Price Uptrend Is Far From Over

Ross Stores’ (NASDAQ: ROST) stock price is in an uptrend, and its Q4 2025 earnings release proves that it isn’t over. Including top- and bottom-line outperformance, compounded by robust

Mirum Completes Enrollment & Screening in Liver Disease Studies
Mirum Completes Enrollment & Screening in Liver Disease Studies

Mirum Pharmaceuticals MIRM announced that it has completed enrollment in the phase III AZURE-1 study, evaluating its pipeline candidate, brelovitug, for the treatment of chronic hepatitis delta

Here's Why Gold Fields (GFI) Could be Great Choice for a Bottom Fisher
Here's Why Gold Fields (GFI) Could be Great Choice for a Bottom Fisher

A downtrend has been apparent in Gold Fields (GFI) lately. While the stock has lost 14.4% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last

Illinois Tool Exhibits Strong Prospects Despite Persisting Headwinds
Illinois Tool Exhibits Strong Prospects Despite Persisting Headwinds

Illinois Tool Works Inc. ITW is gaining from solid momentum across most of its segments. Growth in the institutional and food retail markets in North America, along with higher service revenues and

Here's Why It is Worth Investing in Parker-Hannifin Stock Now
Here's Why It is Worth Investing in Parker-Hannifin Stock Now

Parker-Hannifin Corporation PH is poised to benefit from strength across its businesses, strategic acquisitions and focus on operational excellence. The company remains focused on investing in

Is Accel Entertainment (ACEL) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is Accel Entertainment (ACEL) Stock Outpacing Its Consumer Discretionary Peers This Year?

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Accel Entertainment (ACEL) one of those

Figma's AI Strategy: Is it the Key Driver of Future Expansion?
Figma's AI Strategy: Is it the Key Driver of Future Expansion?

Figma FIG is integrating AI in its workflow and getting solid results. Figma Make, which is an AI-assisted creativity tool, has experienced 70% sequential growth in weekly active users, with more

BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease
BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent.

With this approval

Carter's Shares Rise 5% Post Q4 Earnings: What Should You Know?
Carter's Shares Rise 5% Post Q4 Earnings: What Should You Know?

Shares of Carter's, Inc. CRI have gained roughly 5% since it reported its fourth-quarter 2025 earnings on Feb. 27, 2026. The company reported sales and earnings beat in the fourth quarter, with the

Amphenol Taps Multiple End Markets: Can Diversification Boost Growth?
Amphenol Taps Multiple End Markets: Can Diversification Boost Growth?

Amphenol’s APH broad exposure across multiple end markets is strengthening its long-term growth prospects. The company operates across a wide range of industries, including IT and data